Roche Holding AG (RHHVF)
OTCMKTS · Delayed Price · Currency is USD
446.03
+13.24 (3.06%)
At close: Sep 25, 2026
Roche Holding AG Market Cap
Roche Holding AG has a market cap or net worth of $348.31 billion as of September 25, 2026. Its market cap has increased by 32.92% in one year.
Market Cap
348.31B
Enterprise Value
381.61B
Revenue
77.92B
Ranking
n/a
PE Ratio
22.80
Stock Price
$446.03
ChartMarket Cap Chart
Since January 2, 1992, Roche Holding AG's market cap has increased from 8.76B to 348.31B, an increase of 3,876.71%. That is a compound annual growth rate of 11.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 348.31B | 5.06% |
| Dec 30, 2025 | 331.52B | 46.55% |
| Dec 30, 2024 | 226.23B | -3.34% |
| Dec 29, 2023 | 234.04B | -9.76% |
| Dec 30, 2022 | 259.35B | -22.73% |
| Dec 30, 2021 | 335.62B | 12.23% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 842.92M |
| Silence Therapeutics | 675.55M |
| Nika Pharmaceuticals | 431.19M |
| American Oncology Network | 371.06M |
| CytoDyn | 305.93M |
| Northwest Biotherapeutics | 272.22M |
| Elite Pharmaceuticals | 265.82M |
| Glorywin Entertainment Group | 234.77M |